JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Cliff K. Choong
Tracey J. Guthrie
Eric N. Mendeloff
Charles B. Huddleston
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choong, C. K.
Right arrow Articles by Huddleston, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Choong, C. K.
Right arrow Articles by Huddleston, C. B.
Related Collections
Right arrow Lung - transplantation
Right arrow Congenital - acyanotic
Right arrow Congenital - cyanotic
Right arrow Transplantation - heart

J Thorac Cardiovasc Surg 2005;129:661-669
© 2005 The American Association for Thoracic Surgery

Cardiothoracic Transplantation

Repair of congenital heart lesions combined with lung transplantation for the treatment of severe pulmonary hypertension: A 13-year experience

Cliff K. Choong, FRACSa, Stuart C. Sweet, MDb, Tracey J. Guthrie, BSNa, Eric N. Mendeloff, MDa, Fabio J. Haddad, MDa, Pam Schuler, MDb, Maite De La Morena, MD,b, Charles B. Huddleston, MDa,*

a Division of Cardiothoracic Surgery,
b Department of Surgery, and Division of Pediatric Allergy/Pulmonary Medicine, Washington University School of Medicine, St Louis Children's Hospital, St Louis, Mo

Read at the Eighty-fourth Annual Meeting of The American Association for Thoracic Surgery, Toronto, Ontario, Canada, April 25-28, 2004.

Received for publication April 26, 2004; accepted for publication July 26, 2004.

* Address for reprints: Charles B. Huddleston, MD, No. 1 Children's Place, Suite 5S 50, Children's Hospital, St Louis, MO 63110 (E-mail: choongc{at}msnotes.wustl.edu).

OBJECTIVE: In patients with severe pulmonary hypertension associated with congenital heart disease, we prefer to perform repair of the congenital heart disease and lung transplantation whenever feasible so as to augment the donor pool and avoid the cardiac complications associated with heart transplantation. We report our experience with repair of congenital heart disease and lung transplantation and compare the results with those of patients who underwent heart-lung transplantation during the same period.

METHODS: The records of patients who had repair of congenital heart disease and lung transplantation (n = 35) and heart-lung transplantation (n = 16) between 1990 and 2003 were reviewed.

RESULTS: The underlying congenital heart disease in the repair of congenital heart disease and lung transplantation group included transposition of great vessels (n = 2), atrioventricular canal defect (n = 2), ventricular septal defect (n = 9), pulmonary venous obstruction (n = 7), scimitar syndrome (n = 2), pulmonary arterial atresia or stenosis (n = 5), and others (n = 8). Thirteen of the patients undergoing repair of congenital heart disease and lung transplantation (37.1%) had the congenital heart disease repaired before lung transplantation; the remaining congenital heart disease repairs were performed concurrently with transplantation. Sixteen patients underwent heart-lung transplantation because of poor left ventricular function or single-ventricle anatomy. Freedoms from bronchiolitis obliterans at 1, 3, and 5 years were 72.9%, 54.7%, and 54.7% for the repair of congenital heart disease and lung transplantation group and 77.8%, 51.9%, and 38.9% for the heart-lung transplantation group, respectively. Survivals at 1, 3, and 5 years were 62.9%, 51.4%, and 51.4% for the repair of congenital heart disease and lung transplantation group and 66.5%, 66.5%, and 60% for the heart-lung transplantation group, respectively.

CONCLUSION: Repair of congenital heart disease and lung transplantation is a feasible treatment option. Long-term outcome is determined by associated complications related to lung transplantation. Despite the complexity of combined congenital heart disease repair with lung transplantation and the resulting perioperative morbidity, the patients had similar outcomes to those of patients who underwent heart-lung transplantation.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
S. D. Force, B. Kogon, A. Pelaez, D. C. Neujahr, A. M. Ramirez, D. L. Miller, and E. C. Lawrence
Bilateral Lung Transplant With Pulmonary Thromboendarterectomy for Eisenmenger's Syndrome
Ann. Thorac. Surg., March 1, 2008; 85(3): 1097 - 1099.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
H. Goerler, A. Simon, B. Gohrbandt, C. Hagl, P. Oppelt, J. Weidemann, A. Haverich, and M. Strueber
Heart lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience
Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 926 - 931.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
T. P. Graham Jr
The Year in Congenital Heart Disease
J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2545 - 2553.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The American Association for Thoracic Surgery.